demographic and surgical variables were comparable between the two series. Furthermore, the small sample size of this study may not exclude a high risk of α statistical error. Because of these limitations, it is difficult to differentiate whether the improved renal function parameters obtained in this study are attributable to the natural recovery process of AKI or the efficiency of fenoldopam. To address this issue, multicentre randomized controlled trials with a large sample size are still needed.
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To the Editor:
In a recent study by Biancofiore et al. [1] evaluating the effect of intravenous fenoldopam on acute renal injury (AKI) after orthotopic liver transplantation, AKI was determined according to the Acute Kidney Injury Network criteria within 7 days from surgery. In fact, the Acute Kidney Injury Network criteria require the use of a 48-h time window. Furthermore, it was unclear why only stage 2 AKI was included, though stages 1 and 3 AKI are also common after liver transplantation [2] .
This single-arm prospective study showed that serum creatinine levels significantly decreased 48 and 72 h after intravenous fenoldopam. It has been shown that serum creatinine levels rapidly recover back to normal limits within 2 days or less in about 50 % of patients with postoperative AKI [2] . The patients given fenoldopam in the current study showed better renal function parameters compared to a historical cohort including comparable AKI patients not given fenoldopam, but the authors did not specify whether This letter refers to the article doi:10.1007/s00540-014-1951-2.
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